Results 11 to 20 of about 23,995 (263)
Introduction: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common X-linked enzymopathy, highly prevalent in areas where malaria is or has been endemic. Prevalence of G6PD deficiency and characterization of G6PD variants in females from
Sumalai Dechyotin +6 more
doaj +5 more sources
Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification [PDF]
Caterina Nannelli +4 more
openalex +3 more sources
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an X-linked genetic disorder, is associated with increased risk of jaundice and kernicterus at birth.
Athena Anderle +5 more
doaj +3 more sources
HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study. [PDF]
Bentley AR +8 more
europepmc +2 more sources
Prevalence of G6PD deficiency and G6PD variants amongst the southern Thai population [PDF]
Background Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme essential for NADPH production and protecting cells, especially red blood cells, from free radicals.
Manit Nuinoon +7 more
doaj +2 more sources
Objectives The characteristic of glucose-6-phosphate dehydrogenase (G6PD) deficiency is red blood cell (RBC) destruction in response to oxidative stress.
Hong-Feng Liang +4 more
doaj +1 more source
Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation
Background Oxidative Stress, an imbalance in the pro-oxidant/antioxidant homeostasis, occurs in many physiological and non-physiological processes and several human diseases, including diabetes mellitus (DM) and glucose-6-phosphate dehydrogenase (G6PD ...
Naif S. Karadsheh +3 more
doaj +1 more source
Evaluation of the Diagnostic Accuracy of the Quantitative Point-of-Care SD Biosensor Standard G6PD Test for Assessment of G6PD Deficiency in Infectious Diseases. [PDF]
ABSTRACT Background G6PD deficiency affects about 500 million people worldwide and is prevalent in many malaria‐endemic settings. People with G6PD deficiency are at risk of hemolysis when exposed to certain medications, including 8‐aminoquinoline drugs used to treat Plasmodium vivax malaria.
da Silva FRM +7 more
europepmc +2 more sources
Objective: To determine the frequency of glucose-6-phosphate dehydrogenase (G6PD) deficiency in neonates presenting with indirect hyperbilirubinemia. Methods: A prospective cross-sectional study was conducted at Neonatal intensive care unit (NICU) of ...
Ajea Rani, Mashal Khan
doaj +1 more source

